LDLR and atherosclerosis: A single injection of AAV-PCSK9DY is sufficient to cause downregulation of LDL-R, inducing hyperlipidemia and atherosclerosis in mice, where plaque formation is similar to humans (Roche-Molina et al., 2015; Goettsch et al., 2016).